AGL Relative Valuation
AGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AGL is overvalued; if below, it's undervalued.
Historical Valuation
agilon health inc (AGL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -27.23. The fair price of agilon health inc (AGL) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.73
Fair
-1.18
PE
1Y
3Y
5Y
Trailing
Forward
-0.04
EV/EBITDA
agilon health inc. (AGL) has a current EV/EBITDA of -0.04. The 5-year average EV/EBITDA is 105.49. The thresholds are as follows: Strongly Undervalued below -885.48, Undervalued between -885.48 and -389.99, Fairly Valued between 600.98 and -389.99, Overvalued between 600.98 and 1096.46, and Strongly Overvalued above 1096.46. The current Forward EV/EBITDA of -0.04 falls within the Historic Trend Line -Fairly Valued range.
-0.02
EV/EBIT
agilon health inc. (AGL) has a current EV/EBIT of -0.02. The 5-year average EV/EBIT is -89.15. The thresholds are as follows: Strongly Undervalued below -287.59, Undervalued between -287.59 and -188.37, Fairly Valued between 10.07 and -188.37, Overvalued between 10.07 and 109.29, and Strongly Overvalued above 109.29. The current Forward EV/EBIT of -0.02 falls within the Historic Trend Line -Fairly Valued range.
0.05
PS
agilon health inc. (AGL) has a current PS of 0.05. The 5-year average PS is 1.93. The thresholds are as follows: Strongly Undervalued below -2.08, Undervalued between -2.08 and -0.07, Fairly Valued between 3.94 and -0.07, Overvalued between 3.94 and 5.94, and Strongly Overvalued above 5.94. The current Forward PS of 0.05 falls within the Historic Trend Line -Fairly Valued range.
-2.75
P/OCF
agilon health inc. (AGL) has a current P/OCF of -2.75. The 5-year average P/OCF is 602.70. The thresholds are as follows: Strongly Undervalued below -1929.28, Undervalued between -1929.28 and -663.29, Fairly Valued between 1868.69 and -663.29, Overvalued between 1868.69 and 3134.67, and Strongly Overvalued above 3134.67. The current Forward P/OCF of -2.75 falls within the Historic Trend Line -Fairly Valued range.
-2.41
P/FCF
agilon health inc. (AGL) has a current P/FCF of -2.41. The 5-year average P/FCF is 680.70. The thresholds are as follows: Strongly Undervalued below -4699.58, Undervalued between -4699.58 and -2009.44, Fairly Valued between 3370.84 and -2009.44, Overvalued between 3370.84 and 6060.98, and Strongly Overvalued above 6060.98. The current Forward P/FCF of -2.41 falls within the Historic Trend Line -Fairly Valued range.
agilon health inc (AGL) has a current Price-to-Book (P/B) ratio of 0.97. Compared to its 3-year average P/B ratio of 4.50 , the current P/B ratio is approximately -78.36% higher. Relative to its 5-year average P/B ratio of 3.85, the current P/B ratio is about -74.72% higher. agilon health inc (AGL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -7.80%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.49% , the current FCF yield is about -100.00% lower.
0.97
P/B
Median3y
4.50
Median5y
3.85
-29.49
FCF Yield
Median3y
-7.80
Median5y
-5.49
Competitors Valuation Multiple
The average P/S ratio for AGL's competitors is 4.82, providing a benchmark for relative valuation. agilon health inc Corp (AGL) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -1.08%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AGL decreased by 62.08% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 1.45B to 1.44B.
The secondary factor is the Margin Expansion, contributed -4.24%to the performance.
Overall, the performance of AGL in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is agilon health inc (AGL) currently overvalued or undervalued?
What is agilon health inc (AGL) fair value?
How does AGL's valuation metrics compare to the industry average?
What is the current P/B ratio for agilon health inc (AGL) as of Dec 13 2025?
What is the current FCF Yield for agilon health inc (AGL) as of Dec 13 2025?
What is the current Forward P/E ratio for agilon health inc (AGL) as of Dec 13 2025?